Abstract
Substance use and substance use disorders among pregnant and postpartum individuals have risen dramatically, necessitating enhanced clinician education and intervention strategies. This expert review offers obstetricians and gynecologists a comprehensive overview of substance use during the prenatal and postpartum periods. We discuss the epidemiology, maternal and fetal adverse effects, as well as treatment approaches for major substances: nicotine, cannabis, alcohol, benzodiazepines, stimulants, and opioids. Additionally, we address the ethical and legal implications of substance use during pregnancy and emphasize the importance of equitable and nonstigmatizing care. By integrating evidence-based practices, we aim to support obstetricians and gynecologists in providing optimal care for pregnant and postpartum individuals affected by substance use disorders.
Original language | English |
---|---|
Pages (from-to) | 337-353.e1 |
Journal | American Journal of Obstetrics and Gynecology |
Volume | 232 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2025 |
Keywords
- alcohol
- benzodiazepines
- cannabis
- comprehensive overview of substance use
- epidemiology
- ethics
- intervention
- maternal and fetal adverse effects
- nicotine
- obstetric complications
- opioids
- postpartum substance disorders
- substance use